SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-043306
Filing Date
2024-04-10
Accepted
2024-04-10 15:34:43
Documents
19
Period of Report
2024-04-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-20240410.htm   iXBRL DEF 14A 1344206
2 GRAPHIC img216180643_0.jpg GRAPHIC 16460
3 GRAPHIC img216180643_1.jpg GRAPHIC 4688
4 GRAPHIC img216180643_2.jpg GRAPHIC 16460
5 GRAPHIC img216180643_3.jpg GRAPHIC 277806
6 GRAPHIC img216180643_4.jpg GRAPHIC 282594
7 GRAPHIC img216180643_5.jpg GRAPHIC 4688
8 GRAPHIC img216180643_6.jpg GRAPHIC 231514
9 GRAPHIC img216180643_7.jpg GRAPHIC 77413
  Complete submission text file 0000950170-24-043306.txt   4089407

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20240410.xsd EX-101.SCH 25985
22 EXTRACTED XBRL INSTANCE DOCUMENT evok-20240410_htm.xml XML 162556
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 24835591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)